reference/34140975

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34140975

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2072-6694
issueIdentifier	12
pageRange	2872-
publicationName	Cancers
startingPage	2872
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_aa048e23fd0358a0129a26ab8c57f3bb
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e35ab07420e1bbdec8203f31b0dad099 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b72c627de14f009d4798fa3f74ef4c33 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fc6b37a3f80b0c35d7c94a2ad900ec14
bibliographicCitation	Abu-Khalaf M, Wang C, Zhang Z, Luo R, Chong W, Silver DP, Fellin F, Jaslow R, Lopez A, Cescon T, Jiang W, Myers R, Wei Q, Li B, Cristofanilli M, Yang H. Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism. Cancers (Basel). 2022 Jun 10;14(12). PMID: 35740538; PMCID: PMC9221535.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1639-0480 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9caaae327976ecc9e11c0286694302bd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bf18d3a07d4ab7896c00c9076bf20de9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3200-8977 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eaf42664e0c8b797ad2fa40db095d410 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6fc0e8f9ed0a6227452892d6a4d7930 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_830e788fa01a8fb38a53251fb4548e8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d47051312fdc71b3b6137104dd60cebc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b5c90830580947832d0c47050b4bb6b http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5280-0999 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2baa20f864dd10dc532d471d904c60ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6cf84589303737700528f2cb6d483bab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddc984d07806902647c4d9b88170b443 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7560691fc159fbf8911157fad52371e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4888-7547
date	2022-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.3390/cancers14122872 https://pubmed.ncbi.nlm.nih.gov/PMC9221535 https://pubmed.ncbi.nlm.nih.gov/35740538
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37563 https://portal.issn.org/resource/ISSN/2072-6694
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_646caaa7c99b02cebac462a51ebcdd71 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cc6fd3f8a7671f5f18f7cc414a6e4ebd http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11318 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9455a7be1a7c0dbb6de4ba8898dff00c http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.11.22 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f164b5bdd713c74bc4bd2b0bc727f5b2 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c7be83279551b50c0e81dc2dbfe3c5d8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9d7fe60f25abdf582afc7cdca238bde8 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5330286 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4362b20f0768d2e42b515798671d21b7 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_eb68ffb956a9926a9e73fc09911fb509 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7ed75134b36b0e173fb44798462e4e66 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c3addd02e769f33d86f94bb13502ccd5

Total number of triples: 54.